HALO Prostate AI

HALO Prostate AI is a CE-IVD certified deep learning-based screening tool designed to assist pathologists in the identification and grading of prostate cancer in core needle biopsies. The algorithm automatically analyzes all appropriate case slides and notifies pathologists of cases with suspected findings directly in their native workflow.

– Fast

– Intuitive

– Accurate

Breast IHC AI

Breast IHC AI is an automated, AI-based decision-support tool that standardizes scoring of HER2, ER, PR, and Ki67 IHC on whole slide images in accordance with clinical scoring guidelines.

– Standardize biomarker evaluation

– Increase your workflow efficiency

– Complement your expertise

Lung PD-L1 AI

Lung PD-L1 AI is an automated, AI-based decision-support tool that standardizes scoring of PD-L1 IHC in non-small cell lung cancer (NSCLC) on whole slide images in accordance with clinical scoring guidelines.

– Standardize PD-L1 evaluation

– Increase your workflow efficiency

– Complement your expertise

SlideQC BF

SlideQC BF for HALO AP® is an automated, AI-powered application for H&E-stained digitized slides that detects the most common artifacts including air bubbles, dust/debris, folds, out-of-focus areas, and pen marks generated during the process of slide preparation and whole slide imaging.

– Improve workflow efficiency

– Increase staff availability

– Future proof your lab

HALO AI Prostate is CE-marked for in-vitro diagnostic use in Europe, the UK, and Switzerland. HALO AI Prostate is For Research Use Only in the USA and is not FDA cleared for clinical diagnostic use. HALO AI Prostate is accessed via the HALO AP® enterprise digital pathology platform.

Breast IHC AI is For Research Use Only and not intended for clinical diagnostic use. Breast IHC AI is accessed via the HALO AP® enterprise digital pathology platform.

Lung PD-L1 AI is For Research Use Only and not intended for clinical diagnostic use. Lung PD-L1 AI is accessed via the HALO AP® enterprise digital pathology platform.

SlideQC BF is intended to be used as a quality control tool for whole slide images and is not regulated as a medical device in the EU/UK. SlideQC BF is for Research Use Only in the USA and is not FDA cleared for clinical diagnostic use. SlideQC BF is accessed via the HALO AP® enterprise digital pathology platform.

HALO AP® is CE-IVDR marked for in-vitro diagnostic use in Europe, the UK, and Switzerland. HALO AP® is For Research Use Only in the USA and is not FDA cleared for clinical diagnostic use. In addition, HALO AP® provides built-in compliance with FDA 21 CFR Part 11, HIPAA, and GDPR.